Evidence map›Paper›PMID 27027927›Full record

ArticleJournal of the American Chemical Society2016

Nitrodibenzofuran: A One- and Two-Photon Sensitive Protecting Group That Is Superior to Brominated Hydroxycoumarin for Thiol Caging in Peptides.

M Mohsen Mahmoodi, Daniel Abate-Pella, Tom J Pundsack, Charuta C Palsuledesai, Philip C Goff, David A Blank, Mark D Distefano

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 73 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Dual photo-controlled release system for fipronil and dinotefuran.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2023
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Using photocaging for fast time-resolved structural biology studies.Acta crystallographica. Section D, Structural biology · 2021
    Review
  12. Photoclick Chemistry: A Bright Idea.Chemical reviews · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Light: A Magical Tool for Controlled Drug Delivery.Advanced functional materials · 2020
    Article
  18. Article
  19. Article
  20. Photobodies: Light-Activatable Single-Domain Antibody Fragments.Angewandte Chemie (International ed. in English) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

M Mohsen MahmoodiDepartment of Chemistry, University of Minnesota , Minneapolis, Minnesota 55455, United States.
Daniel Abate-PellaDepartment of Chemistry, University of Minnesota , Minneapolis, Minnesota 55455, United States.
Tom J PundsackDepartment of Chemistry, University of Minnesota , Minneapolis, Minnesota 55455, United States.
Charuta C PalsuledesaiDepartment of Chemistry, University of Minnesota , Minneapolis, Minnesota 55455, United States.
Philip C GoffDepartment of Chemistry, University of Minnesota , Minneapolis, Minnesota 55455, United States.
David A BlankDepartment of Chemistry, University of Minnesota , Minneapolis, Minnesota 55455, United States.
Mark D DistefanoDepartment of Chemistry, University of Minnesota , Minneapolis, Minnesota 55455, United States.
University of Minnesota · US

Funding

Enzymatic Protein LabelingR01GM084152 · NIGMS · UNIVERSITY OF MINNESOTA · PI DISTEFANO, MARK D · 2010 to 2019
$2.6M
LIGHT ACTIVATED ANTI-CANCER DRUGSR21CA185783 · NCI · UNIVERSITY OF MINNESOTA · PI DISTEFANO, MARK D · 2014 to 2015
$338k
NCI NIH HHS R21 CA185783NIGMS NIH HHS R01 GM084152
6 · The paper itself

Abstract

Photoremovable protecting groups are important for a wide range of applications in peptide chemistry. Using Fmoc-Cys(Bhc-MOM)-OH, peptides containing a Bhc-protected cysteine residue can be easily prepared. However, such protected thiols can undergo isomerization to a dead-end product (a 4-methylcoumarin-3-yl thioether) upon photolysis. To circumvent that photoisomerization problem, we explored the use of nitrodibenzofuran (NDBF) for thiol protection by preparing cysteine-containing peptides where the thiol is masked with an NDBF group. This was accomplished by synthesizing Fmoc-Cys(NDBF)-OH and incorporating that residue into peptides by standard solid-phase peptide synthesis procedures. Irradiation with 365 nm light or two-photon excitation with 800 nm light resulted in efficient deprotection. To probe biological utility, thiol group uncaging was carried out using a peptide derived from the protein K-Ras4B to yield a sequence that is a known substrate for protein farnesyltransferase; irradiation of the NDBF-caged peptide in the presence of the enzyme resulted in the formation of the farnesylated product. Additionally, incubation of human ovarian carcinoma (SKOV3) cells with an NDBF-caged version of a farnesylated peptide followed by UV irradiation resulted in migration of the peptide from the cytosol/Golgi to the plasma membrane due to enzymatic palmitoylation. Overall, the high cleavage efficiency devoid of side reactions and significant two-photon cross-section of NDBF render it superior to Bhc for thiol group caging. This protecting group should be useful for a plethora of applications ranging from the development of light-activatable cysteine-containing peptides to the development of light-sensitive biomaterials.

Indexed as

Antineoplastic AgentsBenzofuransCell Line, TumorCell MembraneCoumarinsCysteineCytosolFarnesyl-Diphosphate FarnesyltransferaseFemaleGolgi ApparatusHalogenationHumansIndicators and ReagentsOvarian NeoplasmsPeptidesPhotochemical Processes3-nitrodibenzofuranAntineoplastic AgentsBenzofuransCoumarinsCysteineFarnesyl-Diphosphate FarnesyltransferaseIndicators and ReagentsPeptidesSulfhydryl Compounds

Identifiers

PMID27027927
PMCPMC5026405
OpenAlexW2324331568

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.